Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP14 | Q460N5 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 3/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | FADS1 | O60427 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25686202 | 0.88 | PARP14 (0.40) | PARP14ALOX5PRKDCEGFR | |
| SCHEMBL24432220 | 0.86 | FADS1 (0.35) | FADS1 | |
| SCHEMBL21446453 | 0.85 | PARP14 (0.49) | PARP14ALOX5PRKDCEGFR | |
| SCHEMBL24432378 | 0.85 | ALDH1A1 (0.32) | — | |
| SCHEMBL25686275 | 0.84 | FADS1 (0.34) | FADS1 | |
| SCHEMBL25715945 | 0.83 | — | — | |
| SCHEMBL19147809 | 0.81 | ALOX5 (0.46) | PARP14ALOX5PRKDCEGFR | |
| SCHEMBL25686267 | 0.81 | ALDH1A1 (0.35) | FADS1 | |
| SCHEMBL24432409 | 0.81 | ALDH1A1 (0.37) | FADS1 | |
| SCHEMBL25686284 | 0.81 | RAB9A (0.33) | FADS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2021121230-A1 | COMPOUND, APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME | 北京鼎材科技有限公司 | 2021-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | L1CAM, VDAC2, CD274 | PARP14 714/4885ALOX5 1763/4885PRKDC 3189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.